14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 ALXO stock ended at $15.36. This is 7.58% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 12.59% from a day low at $15.21 to a day high of $17.13.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical ALX Oncology Holdings Inc. prices

Date Open High Low Close Volume
Mar 28, 2024 $11.45 $11.45 $10.60 $11.15 1 052 159
Mar 27, 2024 $11.61 $11.66 $10.95 $11.41 197 173
Mar 26, 2024 $11.85 $11.89 $11.17 $11.19 254 568
Mar 25, 2024 $11.75 $12.17 $11.50 $11.72 268 811
Mar 22, 2024 $12.05 $12.37 $11.51 $11.74 515 191
Mar 21, 2024 $12.24 $12.69 $12.04 $12.51 580 625
Mar 20, 2024 $11.52 $12.18 $11.35 $12.00 250 424
Mar 19, 2024 $11.20 $11.87 $11.06 $11.56 396 603
Mar 18, 2024 $11.10 $11.26 $10.78 $10.95 255 494
Mar 15, 2024 $11.14 $11.67 $10.96 $11.30 515 684
Mar 14, 2024 $11.49 $11.49 $10.80 $11.15 378 734
Mar 13, 2024 $12.26 $12.37 $11.04 $11.60 489 273
Mar 12, 2024 $13.41 $13.50 $12.31 $12.37 820 835
Mar 11, 2024 $15.58 $15.58 $13.11 $13.46 803 185
Mar 08, 2024 $14.12 $16.08 $13.30 $15.21 1 005 884
Mar 07, 2024 $14.85 $16.39 $14.69 $16.24 290 858
Mar 06, 2024 $15.12 $15.25 $14.70 $14.77 301 980
Mar 05, 2024 $14.44 $14.92 $14.44 $14.77 199 480
Mar 04, 2024 $15.26 $15.28 $14.59 $14.70 298 579
Mar 01, 2024 $14.73 $15.26 $14.69 $15.03 436 209
Feb 29, 2024 $14.87 $15.42 $14.60 $14.67 531 121
Feb 28, 2024 $16.17 $16.17 $14.03 $14.51 647 455
Feb 27, 2024 $16.81 $16.99 $15.88 $16.41 302 366
Feb 26, 2024 $15.76 $17.26 $15.58 $16.45 864 791
Feb 23, 2024 $16.13 $16.29 $15.66 $15.85 207 467
Click to get the best stock tips daily for free!

About ALX Oncology Holdings Inc.

ALX Oncology Holdings. ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hodgkin's lymphoma, as well as a range of solid tumor indications, including head and neck squamous cell c... ALXO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT